Sei Investments CO Allogene Therapeutics, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $12,662 - $21,202	1,227 Added 9.71%	13,864 $150,000
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $85,678 - $155,182	12,637 New	12,637 $144,000
Q3 2020 Nov 06, 2020	SELL	$32.38 - $44.96 $289,801 - $402,392	-8,950 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$18.39 - $54.04 $164,590 - $483,658	8,950 New	8,950 $383,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.